ATYR - aTyr Pharma, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$5.13
DETAILS
HIGH:
$17.00
LOW:
$1.00
MEDIAN:
$1.25
CONSENSUS:
$5.13
UPSIDE:
946.94%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | -717.4% |
| EBIT Margin | -40856.3% |
| EBITDA Margin | -40038.9% |
| Operating Margin | -40856.3% |
| Pretax Margin | -39009.5% |
| Cont. Ops Margin | -39009.5% |
| Net Margin | -39009.5% |
| Bottom Line Margin | -39009.5% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 5.30 |
| Quick Ratio | 5.30 |
| Solvency Ratio | -2.700 |
| Cash Ratio | 0.71 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-0.98
Peers avg: 32.5
|
| PEG Ratio | 0.14 |
| Forward PEG | 0.14 |
| Price/Book | 1.08 |
| Price/Sales | 383.25 |
| Price/FCF | -1.17 |
| Price/Op Cash Flow | -1.17 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.1278 |
| Debt/Equity | 0.1783 |
| Debt/Capital | 0.1513 |
| Long-Term Debt/Capital | 0.0000 |
| Financial Leverage | 1.40 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.00 |
| Operating Cash Flow Ratio | -4.092 |
| Operating Cash Flow/Sales | -32624.2% |
| Free Cash Flow/Operating Cash Flow | 100.1% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -51.89 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | -42.28 |
| Operating Cash Flow Coverage | -5.15 |
| Capital Expenditure Coverage | -805.01 |
| Dividend + Capital Expenditure Coverage | -805.01 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.00 |
| EPS | -0.797 |
| Debt/Share | 0.1294 |
| Cash/Share | 0.85 |
| Book Value/Share | 0.72 |
| Tangible BV/Share | 0.72 |
| Equity/Share | 0.73 |
| Operating Cash Flow/Share | -0.667 |
| Capital Expenditure/Share | 0.001 |
| FCF/Share | -0.667 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.955 |
| Price/Fair Value | 1.08 |
| Debt/Market Cap | 0.0201 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -0.97 |